Other
Fasting Conditions
0
Pipeline Programs↗
11
Active Trials↗
39
Companies Involved↗
Fasting Conditions is an early-stage landscape with 0 programs across 39 companies. The most active players are Teva, Novartis, Par Pharmaceutical, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
506
clinical trials
Completed459 · 91%
Unknown status27 · 5%
Withdrawn7 · 1%
Not yet recruiting5 · 1%
Recruiting4 · 1%
Active, not recruiting2 · 0%
Other2 · 0%
Clinical Trials
Trial Activity
506 trials
A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Healthy Adult Participants Under Fasting Conditions (Pilot)
Active, not recruiting·
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·Phase 1·NCT06326671·39 enrolled
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·Phase 1·NCT06326671·39 enrolledA Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions
Active, not recruiting·Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·Phase 1·NCT06487416·186 enrolled
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·Phase 1·NCT06487416·186 enrolledPage 1 of 34
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)